Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com

BPC-157 and TB-500 are synthetic peptides commonly studied in laboratory settings for their interaction with biological signaling pathways related to cellular communication, tissue organization, and vascular processes.
BPC-157 is a 15–amino acid peptide originally identified in studies examining protective compounds associated with gastric proteins. In preclinical research environments, it has been investigated for its relationship with pathways involved in angiogenic signaling, cellular migration, and extracellular matrix activity.
TB-500 is a synthetic peptide fragment modeled after thymosin beta-4, a naturally occurring protein that participates in cytoskeletal regulation and cellular movement. Research involving thymosin beta-4 and related peptide fragments has examined their involvement in cell migration, angiogenic signaling, and structural tissue organization.
Due to these characteristics, both peptides are frequently included in laboratory investigations exploring cellular signaling mechanisms and tissue remodeling pathways.
Laboratory studies involving BPC-157 have explored several biological pathways:
Growth factor signaling
Preclinical research has evaluated BPC-157’s interaction with signaling systems involving growth factors such as:
These pathways are widely studied in relation to angiogenesis, cellular migration, and extracellular matrix formation.
Nitric oxide signaling
Experimental models have examined BPC-157 in relation to nitric oxide (NO) pathways, which play a role in endothelial signaling and cellular communication processes.
Connective tissue research models
Studies have evaluated the peptide’s interaction with connective-tissue-related cell types such as fibroblasts and tenocytes, which are involved in extracellular matrix formation and structural tissue organization.
Gastrointestinal research models
Early investigations involving BPC-157 examined its relationship with epithelial tissue and barrier signaling pathways within gastrointestinal research models.
TB-500 is a synthetic analog of thymosin beta-4 used in laboratory research examining cytoskeletal activity and cellular migration.
Research literature has explored several biological processes associated with thymosin beta-4 peptides:
Cell migration
Studies have examined thymosin-related peptides for their involvement in the regulation of actin and cellular movement.
Angiogenic signaling
Research has evaluated thymosin beta-4 pathways related to blood vessel formation and endothelial signaling.
Extracellular matrix organization
Laboratory models have explored the interaction of thymosin-derived peptides with structural components of connective tissue and matrix proteins.
This product is intended strictly for laboratory research and analytical purposes by qualified professionals.
It may be used in controlled laboratory environments to study:
All products sold on this website are intended strictly for laboratory research and analytical purposes. Products are not intended for human or animal consumption and are not intended for therapeutic, diagnostic, or clinical use.
The materials offered are supplied solely for in vitro research conducted by qualified professionals in controlled laboratory environments.
None of the products sold on this website have been approved by the U.S. Food and Drug Administration (FDA) for any use outside of approved pharmaceutical formulations.
By purchasing from this website, the customer acknowledges that they are a qualified researcher or purchasing on behalf of a qualified research professional and agrees that the products will be handled and used in accordance with all applicable laws and regulations.
The purchaser assumes full responsibility for proper handling, storage, and lawful use of these materials.
FOR RESEARCH USE ONLY
These products are intended solely for laboratory
research conducted by qualified professionals.
Not for human or animal consumption.
Not intended for therapeutic, diagnostic,
or clinical use.
These statements have not been evaluated by
the U.S. Food and Drug Administration.
Copyright © 2026 New Day Peptides LLC - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.